Preoperative use of inhaled tiotropium in lung cancer patients with untreated COPD

Respirology

Volumn 14, Issue 5, 2009, Pages 675-679

  Kobayashi, Seiichi ^a   Suzuki, Satoshi ^a   Niikawa, Hiromichi ^a   Sugawara, Takafumi ^a   Yanai, Masaru ^a  

^a JAPANESE RED CROSS SOCIETY   (Japan)

Author keywords

Chronic obstructive pulmonary disease; Lung cancer; Thoracic surgery; Tiotropium

Indexed keywords

TIOTROPIUM BROMIDE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HUMAN; LOBECTOMY; LUNG CANCER; LUNG FUNCTION; LUNG RESECTION; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; SPIROMETRY;

ADMINISTRATION, INHALATION; AGED; BRONCHODILATOR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SCOPOLAMINE DERIVATIVES; TREATMENT OUTCOME;

EID: 68149108270     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2009.01543.x     Document Type: Article

References (21)

1. Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in COPD: a prospective, matched, controlled study. Ann. Intern. Med. 1986 105 : 503 7.
2. Tockman MS, Anthonisen NR, Wright EC, Donithan MG. Airways obstruction and the risk for lung cancer. Ann. Intern. Med. 1987 106 : 512 18.
3. Kearney DJ, Lee TH, Reilly JJ, DeCamp MM, Sugarbaker DJ. Assessment of operative risk in patients undergoing lung resection: Importance of predicted pulmonary function. Chest 1994 105 : 753 9.
4. Licker MJ, Widikker I, Robert J, Frey JG, Spiliopoulos A et al. Operative mortality and respiratory complications after lung resection for cancer: Impact of chronic obstructive pulmonary disease and time trends. Ann. Thorac. Surg. 2006 81 : 1830 7.
5. British Thoracic Society and Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. Guidelines on the selection of patients with lung cancer for surgery. Thorax 2001 56 : 89 108.
6. Colice GL, Shafazand S, Griffin JP, Keenan R, Bolliger CT. Physiologic evaluation of the patients with lung cancer being considered for resectional surgery: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007 132 : 161S 77S.
7. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 2000 160 : 1683 9.
8. Pena VS, Miravitlles M, Gabriel R, Jimenez-Ruiz CA, Villasante C et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000 118 : 981 9.
9. Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A et al. COPD in Japan: the Nippon COPD epidemiology study. Respirology 2004 9 : 458 65.
10. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Diagnosis, Management, and Prevention of COPD. Updated 2007. [Accessed 6 October 2008.] Available from URL: http://www.goldcopd.org/
11. van Noord JA, Bantje TA, Eland ME, Korducki L, Cornelissen PJ. A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease. Thorax 2000 55 : 289 94.
12. Vincken W, van Noord JA, Greefhorst AP, Bantje TA, Kesten S et al. Improved health outcomes in patients with COPD during 1 year's treatment with tiotropium. Eur. Respir. J. 2002 19 : 209 16.
13. Casaburi R, Mahler DA, Jones PW, Wanner A, San PG et al. A long-term evaluation of once-daily inhaled tiotropium inchronic obstructive pulmonary disease. Eur. Respir. J. 2002 19 : 217 24.
14. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R et al. Standardisation of spirometry. Eur. Respir. J. 2005 26 : 319 38.
15. Bobbio A, Chetta A, Ampollini L, Primomo GL, Internullo E et al. Preoperative pulmonary rehabilitation in patients undergoing lung resection for non-small cell lung cancer. Eur. J. Cardiothorac. Surg. 2008 33 : 95 8.
16. Celli B, ZuWallack R, Wang S, Kesten S. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest 2003 124 : 1743 8.
17. Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr., Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 2005 127 : 809 17.
18. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC et al. Effects of smoking intervention and use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994 272 : 1497 505.
19. Burge PS, Calverley PM, Jones PW, Jones PW, Spencer S et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000 320 : 1297 303.
20. Mentzer SJ, Swanson SJ. Treatment of patients with lung cancer and severe emphysema. Chest 1999 116 : 477S 9S.
21. Barrera R, Shi W, Amar D, Thaler HT, Gabovich N et al. Smoking and timing of cessation. Chest 2005 127 : 1977 83.